A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia

Circulation

Volumn 97, Issue 8, 1998, Pages 729-735

  Wittekoek, Marianne E ^b   Pimstone, Simon N ^a   Reymer, Paul W A ^b   Feuth, Lisette ^b   Botma, Gert Jan ^b   Defesche, Joep C ^b   Prins, M ^b   Hayden, Michael R ^a   Kastelein, John J P ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b 416 2125 E Mall ^*

Author keywords

Atherosclerosis; Genetics; Lipoproteins

Indexed keywords

ACETYLCHOLINE; FREE RADICAL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; CORONARY ARTERY DISEASE; DNA DETERMINATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032478291     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.729     Document Type: Article

References (34)

1. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome. In: Scriver CR, Beaudet AC, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw Hill Book Co; 1995;1913-1932.
2. Julien P. High frequency of lipoprotien lipase deficiency in the Quebec population. Can J Cardiol. 1992;8:675-676.
3. Ma Y, Ooi TC, Liu M-SL, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res. 1994;35:1066-1075.
4. Gagné SE, Pimstone SN, Larson MG, Schaefer EJ, Kastelein JJP, Wilson PWF, Ordovas JM, Hayden MR. Effects of lipoprotein lipase gene mutations on plasma lipids: the Framingham Offspring Study. Circulation. 1996;94(suppl I):I-273. Abstract.
5. Reymer PWA, Gagné SE, Groenemeyer BE, Zhang H, Forsyth IJ, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein JJP, Hayden MR. A lipoprotein lipase muution (Asn291Ser) is associated with reduced HDL levels in premature atherosclerosis. Nat Genet. 1995;10:28-33.
6. Reymer PWA, Groenemeyer BE, Gagné SE, Miao L, Appelman EEG, Seidel JC, Kromhout D, Bijvoet SM, van de Oever K, Bruin T, Hayden MR, Kastelein JJP. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet. 1995;4:1543-1549.
7. Reymer PWA, Groenemeyer BE, Ma Y, Appelman EEG, van De Oever K, Bruin T, Seidel JC, Hayden MR, Kastelein JJP. A frequently occurring mutation in the LPL gene contributes to the expression of FCH and FDL and aggravates dyslipidemia in these patients. Atherosclerosis. 1994;109:64. Abstract.
8. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults, J Lipid Res. 1995;36:2104-2112.
9. Shimada M, Ishibashi S, Inaba T, Yagyu H, Harada K, Osuga J-I, Ohashi K, Yazaki Y, Yamada N. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A. 1996;93:7242-7246.
10. Goldstein J, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AC, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw Hill Book Co; 1995; 1981-2030.
11. Slack J. Risk of ischemic heart disease in familial lipoproteinemic states. Lancet. 1969;2:1380-1382.
12. Pimstone SN, Gagné SE. Gagné C, Lupien PJ, Gaudet D, Williams RR, Kotze M, Reymer PWA, Defesche JC, Kastelein JJP. Moorjani S. Hayden MR. Mutations in the gene for lipoprotein lipase: a cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler Thrpmb Vasc Biol. 1995;15:1704-1712.
13. Inazu A, Koizumi H, Kajinami K, Takeda R. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Horn Metah Res. 1992;24:284-288.
14. Seftel HC, Baker SG, Sandlier MP, Forman MB, Joffe HI, Mendelsohn D. Jenkins T, Mieny CJ. A host of hypercholesterolemic homozygotes in South Africa. BMJ. 1980;281:633-636.
15. Kwiterowich PO. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia): a study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest. 1973;53:1237-1249.
16. Technical tips: an efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 1989;5:391.
17. Zhang H, Reymer PWA, Liu M-S, Forsythe IJ, Groenemeyer BE, Frohlich J, Bruiizell JD, Kastelein JJP, Hayden MR, Ma Y. Patients with apoE3 deficiency (E2/E2, E3/E2 and E4/E2) who manifest with hyperlipidemia have increased frequency of an Asn291Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol. 1995;15:1695-17113.
18. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M. Groenemeyer BE. Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud P. A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol. 1995;15:468-478.
19. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC, Enzymatic determination of total serum cholesterol. Clin Client. 1974;20:470-475.
20. 2+ quantification of high density lipoprotein cholesterol: an ultracentrifugation procedure for lipidemic samples. Clin Client. 1978;24:900-904.
21. Buccolo G, David H. Qualitative determination of serum triglycerides by the use of enzymes, Clin Chem. 1973;19:476-482.
22. Friedewald WT, Levy RJ, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultra-centrifuge. Clin Chem. 1972;18:499-502.
23. Demacker PN, Toenhake-Dijkstra H, de Rijke YB, Stalenhoef AF, Stuyt PM, Willems HL. On the presumed inaccuracy of the Friedewald formula in hypertriglyceridernic plasma: a role for imprecise analysis? Clin Chem. 1996;42:1491-1494.
24. Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M. Genotypic and phenotypic variation in familial hypercholesterolemia. Areriosclerosis. 1989;9(suppl I):I-75-I-80.
25. Schrott HG, Goldstein JL, Hazzjrd WR, McGoodwin MM, Motulsky AG. Familial hypercholesterolemia in a large kindred. Ann Intern Med. 1972;76:711-720.
26. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous, familial hypercholesterolemia. Arterioscler Thromb. 1991;11:290-297.
27. Moorjani S, Gagné C, Lupien P-J, Brun D. Plasma triglyceride related decrease in high density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism. 1986;35:311-316.
28. Seed M, Hoppichler F, Reavely D, McCarthy S, Thopson GR. Boerwinkle E, Utermann G. Relation of srum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypcholesterolemia. N Engl J Med. 1990;322:1494-1499.
29. Carmena R, Lussier-Cacan S, Roy M, Minnich A, Lingenhal A, Davignon J. Lp(A) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol. 1996;16:129-136.
30. Ferrières J, Sing CF, Madeleine R, Davignon J, Lussier-Cacan S. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia: sex-specific effects. Arterioscler Thromb. 1994;14:1553-1560.
31. Berglund L, Wiklund O, Egertson G, Olofsson S-O, Eriksson M, Linden T, Bondjen G, Angelin B. Apolipoprotein E phenorypes in familial hypercholesterolemia: importance for expression of disease and response to therapy. J Intern. Med. 1993;233:173-178.
32. Zhang H, Henderson H, Gagné SE, Clee SM, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1996;1302:159-166.
33. 291→Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res. 1996;37:727-738.
34. Pimstone SN, Clee S, Gagné SE, Miao L, Zhang H, Stein EA, Hayden MR. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res. 1996;37:1675-1684.